Mauna Kea Technologies launches CellTolerance at Cleveland Clinic Abu Dhabi

Mauna Kea Technologies has finalized the deployment of its CellTolerance program at Cleveland Clinic Abu Dhabi. This move establishes the clinic as the first medical facility in the Middle East and North Africa (MENA) region to offer the service to its patients.

The CellTolerance program leverages the company's proprietary optical biopsy technology to assist clinicians in diagnostic procedures. By integrating this platform, the hospital aims to enhance the precision of tissue analysis through real-time imaging, potentially reducing the need for traditional invasive biopsy methods.

This expansion represents a strategic step for Mauna Kea Technologies as it seeks to increase its international footprint. The company will monitor the program’s performance at the Abu Dhabi facility as a primary use case for further potential regional scaling.